Editorial: Renal function and related biomarkers in cardiovascular risk assessment and prevention

Editorial: Renal function and related biomarkers in cardiovascular risk assessment and prevention

Bibliographic Details
Main Authors:	Gen-Min Lin, Dexter Canoy
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	biomarkers cardiovascular risk population study prevention renal function
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.1069629/full

Similar Items

Aminopeptidases in Cardiovascular and Renal Function. Role as Predictive Renal Injury Biomarkers
by: Félix Vargas, et al.
Published: (2020-08-01)

High sensitivity troponins: A potential biomarkers of cardiovascular risk for primary prevention
by: Luis Leite, et al.
Published: (2022-11-01)

Effectiveness of Lifestyle Modification vs. Therapeutic, Preventative Strategies for Reducing Cardiovascular Risk in Primary Prevention—A Cohort Study
by: Małgorzata Chlabicz, et al.
Published: (2022-01-01)

Doença cardiovascular e fatores de risco cardiovascular em candidatos a transplante renal Cardiovascular disease and risk factors in candidates for renal transplantation
by: Luís Henrique Wolff Gowdak, et al.
Published: (2005-02-01)

Editorial: Insights in cardiovascular epidemiology and prevention: 2022
by: Gen-Min Lin, et al.
Published: (2023-02-01)

Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk
by: Michael Böhm, et al.
Published: (2022-01-01)

A Sex-Specific Comparative Analysis of Oxidative Stress Biomarkers Predicting the Risk of Cardiovascular Events and All-Cause Mortality in the General Population: A Prospective Cohort Study
by: Martin F. Bourgonje, et al.
Published: (2023-03-01)

YOGA IN CARDIOVASCULAR PATHOLOGY PREVENTION
by: N. T. Vatutin, et al.
Published: (2015-06-01)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
by: Apichard Sukonthasarn, et al.
Published: (2021-03-01)

Cardiovascular risk and kidney function profiling using conventional and novel biomarkers in young adults: the African-PREDICT study
by: A Degenaar, et al.
Published: (2023-04-01)

Race, Biomarkers, and Cardiovascular Disease in Patients With Chronic Kidney Disease
by: Susanne B. Nicholas, et al.
Published: (2022-09-01)

Lipid Biomarkers and Atherosclerosis—Old and New in Cardiovascular Risk in Childhood
by: Mirjam Močnik, et al.
Published: (2023-01-01)

Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers
by: Alyssa M. B. White, et al.
Published: (2020-11-01)

New opportunities for biomarkers in cardiovascular risk stratification. Resolution of Advisory board
by: О. M. Drapkina, et al.
Published: (2021-10-01)

Editorial: Classical and Novel Biomarkers for Cardiovascular Disease
by: Maria Perticone, et al.
Published: (2022-06-01)

Changes in Cardiovascular and Renal Biomarkers Associated with SGLT2 Inhibitors Treatment in Patients with Type 2 Diabetes Mellitus
by: Melpomeni Peppa, et al.
Published: (2023-10-01)

Primary Prevention of Cardiovascular Risk in Lithuania—Results from EUROASPIRE V Survey
by: Gediminas Urbonas, et al.
Published: (2020-03-01)

Editorial: Biomarkers in structural cardiovascular disease: insights into screening, diagnosis and prognosis
by: Vitor Emer Egypto Rosa, et al.
Published: (2023-11-01)

Non-Conventional Risk Factors: “Fact” or “Fake” in Cardiovascular Disease Prevention?
by: Giovanni Cimmino, et al.
Published: (2023-08-01)

Vitamin D-Related Single Nucleotide Polymorphisms as Risk Biomarker of Cardiovascular Disease
by: Paula González Rojo, et al.
Published: (2022-08-01)

A Similar Lifetime CV Risk and a Similar Cardiometabolic Profile in the Moderate and High Cardiovascular Risk Populations: A Population-Based Study
by: Małgorzata Chlabicz, et al.
Published: (2021-04-01)

Editorial: Recent advances on omics and biomarkers research in renal transplantation
by: Xiaoming Ding, et al.
Published: (2023-06-01)

Genetic and phenotypic determinants of blood pressure and other cardiovascular risk factors
by: David Conen, et al.
Published: (2012-12-01)

Estudio piloto de los factores clásicos de riesgo cardiovascular en una comunidad rural del municipio San Diego, Venezuela
by: Marvin Querales, et al.
Published: (2016-12-01)

Editorial: The role of metabolic syndrome and disorders in cardiovascular disease
by: Paola Di Pietro, et al.
Published: (2023-10-01)

Cardiovascular Disease Burden: Evolving Knowledge of Risk Factors in Myocardial Infarction and Stroke through Population-Based Research and Perspectives in Global Prevention
by: GUSTAVO B.F. OLIVEIRA, et al.
Published: (2015-08-01)

NEW MARKERS FOR CARDIOVASCULAR RISK: FROM STUDIES TO CLINICAL GUIDELINES
by: D. A. Anichkov, et al.
Published: (2014-11-01)

NEW MARKERS FOR CARDIOVASCULAR RISK: FROM STUDIES TO CLINICAL GUIDELINES
by: D. A. Anichkov, et al.
Published: (2014-11-01)

Editorial: Physical activity and exercise for the prevention and management of cardiovascular risk and cardiovascular disease
by: Maurizio Volterrani, et al.
Published: (2023-10-01)

Dietary counselling to reduce moderate sodium intake: effects on cardiovascular and renal biomarkers: primary findings of the COSIP and STICK phase II feasibility randomised controlled trialsResearch in context
by: Andrew Smyth, et al.
Published: (2023-03-01)

Primary prevention of cardiovascular disease: focus on improving behavioral risk factors
by: V. S. Chulkov, et al.
Published: (2021-10-01)

Evaluation of cardiovascular diseases risk calculators for CVDs prevention and management: scoping review
by: Mohammed Abd ElFattah Mohammed Darwesh Badawy, et al.
Published: (2022-09-01)

Targets for the prevention of comorbidity of cardiovascular and cancer diseases
by: M. N. Mamedov, et al.
Published: (2022-12-01)

Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future
by: Farah Omran, et al.
Published: (2022-05-01)

Sleeve gastrectomy and one-year outcomes: Impact on cardiovascular, renal and metabolic parameters
by: Maria Irene Bellini, et al.
Published: (2024-01-01)

Renal Stones and Gallstones Correlated with the Ten-Year Risk Estimation of Atherosclerotic Cardiovascular Disease Based on the Pooled Cohort Risk Assessment of Males Aged 40–79
by: Hui-Yu Chen, et al.
Published: (2023-03-01)

Ethnic Variations in Cardiovascular and Renal Outcomes From Newer Glucose‐Lowering Drugs: A Meta‐Analysis of Randomized Outcome Trials
by: Huilin Tang, et al.
Published: (2023-05-01)

Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future Directions
by: Francesco Perone, et al.
Published: (2023-08-01)

Cardiovascular Risk Factors in Children with Obesity, Preventive Diagnostics and Possible Interventions
by: Mirjam Močnik, et al.
Published: (2021-08-01)

Estimated versus observed 10-year atherosclerotic cardiovascular event rates in a rural population-based health initiative: The Heart of New Ulm Project
by: Christopher Van Hove, et al.
Published: (2023-03-01)